Tirzepatide
  1. Home
  2. Mounjaro
  3. Tirzepatide

Tirzepatide

Tirzepatide is a prescription dual GIP and GLP-1 receptor agonist used to improve glycemic control in adults with type 2 diabetes and, for certain formulations, to support chronic weight management. It is available as a once-weekly subcutaneous injection in a prefilled injection pen. Tirzepatide provides effective long-term metabolic management when used alongside a healthy diet and regular physical activity.

BUY NOW

Category

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that helps regulate blood glucose and body weight by enhancing glucose-dependent insulin secretion, reducing glucagon release, slowing gastric emptying, and promoting satiety. It is widely prescribed for the management of type 2 diabetes and selected chronic weight management programs through a once-weekly subcutaneous injection. Manufactured under stringent pharmaceutical quality standards, tirzepatide is supplied in sterile prefilled injection pens across multiple dosage strengths to ensure consistent therapeutic performance. Tirzepatide should be used only under the supervision of a qualified healthcare professional according to the prescribed treatment plan.

Technical Specification

Specification Details
Product Name Tirzepatide
Therapeutic Class Dual GIP and GLP-1 Receptor Agonist
Available Dosage Form Sterile Prefilled Injection Pen
Route of Administration Subcutaneous Injection
Dosing Frequency Once Weekly (As Prescribed)
Storage Refrigerate at 2°C–8°C before first use

Product Also Known As

Tirzepatide, Tirzepatide Injection, Tirzepatide Pen, Weekly Tirzepatide Injection, GIP GLP-1 Receptor Agonist, Diabetes Injection, Weight Management Injection